Dr. Eric Lattmann completed his PhD from the University of Hannover in the department of Synthetic organic chemistry, presently he is working as a Professor in department of medicinal chemistry, at Aston University, United Kingdom. He is the Member of the Pharmacy and Biology Teaching Programmes. He worked as research fellow in University of Aberdeen. He took an active part in the research conducted at Aston University for a collaborative programme with Prof Les Iversen which was launched to design, discover and develop novel CCK antagonists and in other research with collaboration of Prof MJ Tisdale over novel anticancer agents based on butenolides and natural products were synthesized and evaluated in vitro and in vivo. He worked on CCK antagonists in the area of neuroscience and anticancer agents from natural sources and synthetics were prepared and tested. Consequently the idea of a CCK antagonist from a CNS drug towards an anticancer agent was promoted and realized. He worked as a principal investigator for an international research collaboration (UK, US, IN and TH) dedicated to beating CCK related cancers.